Top Stories

House Breaks Record Stalemate to Advance Landmark ‘Crypto Week’ Bills

After a grueling, record-setting nine-hour stalemate, the Republican-led U.S. House of Representatives late Wednesday finally advanced a package of high-stakes…

Read More »

Why Bitcoin Just Hit Another New High

Bitcoin (BTCUSD) has shattered expectations once again. On Monday, the world’s largest cryptocurrency soared to a new all-time high of…

Read More »

Here’s Why Rare Earth Stocks Are Surging

Rare earth stocks are roaring back to life, and investors are taking notice. The recent surge in share prices across…

Read More »

Trump Poised to Launch Another Crypto ETF, Here’s the Full Details

In a bold move to expand his digital asset empire, President Donald Trump’s company, Trump Media & Technology Group (NASDAQ: DJT),…

Read More »

POET Stock is on the Rise Again, Here’s What’s Fueling the Rally

POET Technologies (NASDAQ: POET) (TSXV: PTK) is catching fire again. After starting the week on a down note, shares surged…

Read More »

ProKidney Corp. Skyrockets 515% on Trial Data, But is it a Buy?

Shares of ProKidney Corp. (NASDAQ: PROK) soared 515% on Tuesday, triggering shockwaves across Wall Street after the company unveiled highly…

Read More »

Tokenized Stocks 101: How Blockchain is Transforming Traditional Investing

The line between traditional finance and blockchain technology is disappearing fast, and nowhere is this clearer than in the rise…

Read More »

Robinhood Soars to Record High on Tokenized Stock Rollout

Robinhood Markets (NASDAQ: HOOD) surged to fresh all-time highs this week as the brokerage’s bold leap into tokenized stock trading…

Read More »

Lake Victoria Gold Launches Major Drill Program at Imwelo Project as It Races Toward Production

Lake Victoria Gold (TSXV: LVG) (OTCQB: LVGLF) (FSE: E1K) has officially kicked off a 7,750-metre multi-purpose drill campaign at Area…

Read More »

5 Biotech Stocks With Highly Anticipated Pending Results

The biotech sector remains one of the most dynamic areas of the market, driven by clinical breakthroughs, regulatory decisions, and…

Read More »
Back to top button